N-myc amplification causes down-modulation of MHC class I antigen expression in neuroblastoma

Cell

Volumn 47, Issue 5, 1986, Pages 667-674

  Bernards, Rene ^a   Dessain, Scott K ^a   Weinberg, Robert A ^a,b  

^a WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

^b MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1;

ANIMAL CELL; AUTONOMIC NERVOUS SYSTEM; CANCER CELL CULTURE; CANCER GROWTH; GENE AMPLIFICATION; HEREDITY; HUMAN; METASTASIS; NERVOUS SYSTEM; NEUROBLASTOMA; ONCOGENE C MYB; PRIORITY JOURNAL; RAT;

ANIMAL; ANTIGENS, NEOPLASM; CELL DIVISION; FIBROBLASTS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS; INTERFERON TYPE II; NEOPLASM METASTASIS; NEUROBLASTOMA; PHENOTYPE; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-MYC; RATS; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRANSFECTION;

EID: 0022908929     PISSN: 00928674     EISSN: None     Source Type: Journal    
DOI: 10.1016/0092-8674(86)90509-X     Document Type: Article

References (50)

1. Retinoic acid treatment of human neuroblastoma cells is associated with decreased N-myc expression
2. Pre-early adenovirus 5 gene product regulates synthesis of early viral messenger RNAs
3. Viral oncogenes
4. Amplification of N-myc in untreated human neuroblastoma correlates with advanced disease stage
5. Constitutive c-myc oncogene expression blocks mouse erythroleukaemia cell differentiation but not commitment
6. Post-transcriptional control of myc and p53 expression during differentiation of the embryonal carcinoma cell line F9
7. Markedly decreased expression of class I histocompatibility antigens, protein, and mRNA in human small-cell lung cancer
8. Interferon modulation of c-myc gene expression in cloned Daudi cells: relationship to the phenotype of interferon resistance
9. 1 arrest
10. A proposed staging for children with neuroblastoma
11. Mouse monoclonal antibodies against rat major histocompatibility antigens
12. Expression of N-myc in teratocarcinoma cells and mouse embryos
13. Selective reduction of c-myc mRNA in Daudi cells by human β-interferon
14. Regulation of heat shock protein 70 gene expression by c-myc
15. Transposition and amplification of oncogenerelated sequences in human neuroblastomas
16. d histocompatibility antigen
17. 2-microglobulin expression of neuronal cell lines can be modulated by interferon
18. 2-microglobulin on human neuroblastoma cell lines
19. Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
20. Expression and amplification of the N-myc gene in primary retinoblastoma
21. Nucleotide sequence and evolution of a mammalian alpha-tubulin messenger RNA
22. Amplification and expression of the c-myc oncogene in human lung cancer cell lines
23. L-myc, a new myc-related gene amplified and expressed in human small cell lung cancer
24. Human small-cell lung cancers show amplification and expression of the N-myc gene
25. Mechanism of activation of early viral transcription by the adenovirus E1A gene product
26. Mechanisms of tumor progression
27. 2-microglobulin genes
28. Nuclear localization and DNA binding properties of a protein expressed by human c-myc oncogene
29. bm1 gene in murine embryonal carcinoma cells
30. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens
31. Adenovirus early region 1A enables viral and cellular transforming genes to transform primary cells in culture
32. The neu oncogene: an erbB-homologous gene encoding a 185,000 Mr tumor antigen
33. Expression of class I histocompatibility antigens switched off by highly oncogenic adenovirus 12 transformed rat cells
34. Clonal cell lines from the rat central nervous system
35. Amplified DNA with limited homology to myc cellular oncogene is shared by human neuroblastoma cell lines and a neuroblastoma tumor
36. Enhanced expression of the human gene N-myc consequent to amplification of DNA may contribute to malignant progression of neuroblastoma
37. Human N-myc gene contributes to neoplastic transformation of mammalian cells in culture
38. Association of multiple copies of the N-myc oncogene with rapid progression of neuroblastomas
39. Isolation and partial nucleotide sequence of a cDNA clone for human histocompatibility antigen HLA-B by use of an oligodeoxynucleotide primer
40. Cell surface antigens of clonal teratocarcinoma cells at various stage of differentiation
41. Induction of mammary carcinomas in rats by nitroso-methylurea involves malignant activation of H-ras-1 locus by single point mutation
42. Decreased expression of N-myc precedes retinoic acid-induced morphological differentiation of human neuroblastoma
43. 2-microglobulin on human neuroblastoma cell lines
44. Assay of transforming activity of tumor virus DNA
45. The action of oncogenes in the cytoplasm and in the nucleus
46. Abrogation of metastatic properties of tumour cells by de novo expression of H-2K antigens following H-2 gene transfection
47. Inducible expression of H-2 and la antigens on brain cells
48. Autogenous production of interferon-β switches on HLA genes during differentiation of histiocytic lymphoma U937 cells
49. Identification of human adenovirus early region 1 products using antisera against synthetic peptides corresponding to the predicted carboxy termini
50. MHC-restricted cytotoxic T-cells: studies on the biological role of polymorphic major transplantation antigens determining T-cell restriction-specificity, function, and responsiveness